Funding Events for Vertical: Biopharmaceuticals
← Back to All Verticals
Loading funding events...
Company Name | Funding Type | Date Awarded | Vertical |
---|---|---|---|
PhorMed | Equity | March 26, 2022 | Biopharmaceuticals |
BioCurity Pharmaceuticals | Equity | March 25, 2020 | Biopharmaceuticals |
Bluejay Therapeutics | Series C | May 09, 2024 | Biopharmaceuticals |
BioCurity Pharmaceuticals Inc. | Equity | January 01, 2024 | Biopharmaceuticals |
RS BioTherapeutics | Convertible Notes | April 24, 2024 | Biopharmaceuticals |
Amlogenyx Inc. | Seed | August 02, 2024 | Biopharmaceuticals |
Idrx | Series B | August 07, 2024 | Biopharmaceuticals |
Paradigm Therapeutics | Series A | May 16, 2025 | Biopharmaceuticals |
NLS Pharma | Equity Financing | May 17, 2025 | Biopharmaceuticals |
Idorsia | Debt Restructuring | May 18, 2025 | Biopharmaceuticals |
BioVersys AG | IPO | January 29, 2025 | Biopharmaceuticals |
Helicore Biopharma | Series A | January 28, 2025 | Biopharmaceuticals |
Takeda | Grant | May 19, 2025 | Biopharmaceuticals |
Kailera Therapeutics | Series A | January 04, 2025 | Biopharmaceuticals |
AsclepiX Therapeutics Inc. | Series A | June 24, 2020 | Biopharmaceuticals |
Arrivo BioVentures LLC | Venture | May 26, 2016 | Biopharmaceuticals |
3-V Biosciences | Series D | January 05, 2015 | Biopharmaceuticals |
AusperBio | Series B | December 27, 2024 | Biopharmaceuticals |
Akarna Therapeutics | Series B | February 16, 2016 | Biopharmaceuticals |
BlackThorn Therapeutics | Series A | October 21, 2016 | Biopharmaceuticals |
Concentric Analgesics | Convertible Debt | January 26, 2022 | Biopharmaceuticals |
BioEclipse Therapeutics | Series A-1 | June 25, 2019 | Biopharmaceuticals |
Apollomics | Series A | August 29, 2016 | Biopharmaceuticals |
Genoa Pharmaceuticals | Series A | May 15, 2017 | Biopharmaceuticals |
Gotham Therapeutics | Series A | October 10, 2018 | Biopharmaceuticals |
Good Therapeutics | Series B | December 30, 2021 | Biopharmaceuticals |
Genprex | Undisclosed | November 07, 2016 | Biopharmaceuticals |
GC Therapeutics | Series A | October 05, 2024 | Biopharmaceuticals |
Akrevia Therapeutics | Series A | September 27, 2018 | Biopharmaceuticals |
Chiasma | Series E | March 02, 2015 | Biopharmaceuticals |
Antios Therapeutics | Series A | November 27, 2018 | Biopharmaceuticals |
CODA Biotherapeutics | Series A | September 13, 2018 | Biopharmaceuticals |
Accent Therapeutics | Series A | May 18, 2018 | Biopharmaceuticals |
Constellation Pharmaceuticals | Series A | April 09, 2018 | Biopharmaceuticals |
Biotheryx | Series D | July 28, 2020 | Biopharmaceuticals |
Biolexis Therapeutics | Series A | November 29, 2023 | Biopharmaceuticals |
Aptinyx Inc. | Series A | May 10, 2016 | Biopharmaceuticals |
Basking Biosciences | Series B | February 01, 2024 | Biopharmaceuticals |
ArriVent Biopharma | Series B | March 27, 2023 | Biopharmaceuticals |
Aprea | Series A | November 30, 2018 | Biopharmaceuticals |
Disc Medicine | Series B | September 03, 2021 | Biopharmaceuticals |
ESCAPE Bio | Crossover Financing | September 14, 2020 | Biopharmaceuticals |
E-Scape Bio | Series A Extension | July 12, 2017 | Biopharmaceuticals |
Engage Therapeutics | Series A | September 27, 2017 | Biopharmaceuticals |
Emalex Biosciences | Series C | March 23, 2021 | Biopharmaceuticals |
Day One Biopharmaceuticals | Series A | May 21, 2020 | Biopharmaceuticals |
Effector Therapeutics | Series C | July 24, 2017 | Biopharmaceuticals |
Dance Biopharm Holdings | Venture Capital | April 24, 2019 | Biopharmaceuticals |
Epirium Bio | Series A | December 19, 2019 | Biopharmaceuticals |
Diasome Pharmaceuticals | Series A | July 06, 2017 | Biopharmaceuticals |
Hoth Therapeutics | Series A | February 22, 2018 | Biopharmaceuticals |
HilleVax | Crossover Financing | September 08, 2021 | Biopharmaceuticals |
Inspirna | Series D | July 11, 2022 | Biopharmaceuticals |
IFM Therapeutics | Series A | June 22, 2016 | Biopharmaceuticals |
Inipharm | Series A | November 12, 2020 | Biopharmaceuticals |
ITeos Therapeutics | Series B | April 01, 2020 | Biopharmaceuticals |
Nocion Therapeutics | Series B | March 04, 2024 | Biopharmaceuticals |
Microbion | GF | January 09, 2017 | Biopharmaceuticals |
Noveome Biotherapeutics | Series D | April 09, 2019 | Biopharmaceuticals |
NextCure | Series A, Series B | January 06, 2016 | Biopharmaceuticals |
Nemus Bioscience | Series E | May 04, 2017 | Biopharmaceuticals |
Landos Biopharma | Series B | August 13, 2019 | Biopharmaceuticals |
Lomond Therapeutics | Private Placement Financing | March 28, 2025 | Biopharmaceuticals |
Mithradote Bio | Seed | October 02, 2024 | Biopharmaceuticals |
Moat Biotechnology | Venture | June 13, 2023 | Biopharmaceuticals |
Nuvation Bio | Series A | October 29, 2019 | Biopharmaceuticals |
Montara Therapeutics | Seed | March 13, 2025 | Biopharmaceuticals |
Linnaeus Therapeutics | Series B | September 17, 2019 | Biopharmaceuticals |
Neuvivo | Venture | June 15, 2023 | Biopharmaceuticals |
ReCode Therapeutics | Series A | March 28, 2020 | Biopharmaceuticals |
Quanta Therapeutics | Series D | May 22, 2023 | Biopharmaceuticals |
Regenacy Pharmaceuticals | Series A | March 25, 2020 | Biopharmaceuticals |
SpringWorks Therapeutics | Series B | April 02, 2019 | Biopharmaceuticals |
Tenaya Therapeutics | Series B | October 04, 2019 | Biopharmaceuticals |
Sensei Biotherapeutics | Series B | January 13, 2021 | Biopharmaceuticals |
resTORbio | Series B | November 30, 2017 | Biopharmaceuticals |
Seaport Therapeutics | Series A | April 28, 2024 | Biopharmaceuticals |
Renibus Therapeutics | Series B | September 12, 2023 | Biopharmaceuticals |
Sirnaomics | Series B | May 04, 2016 | Biopharmaceuticals |
Symbiomix Therapeutics | Series A | May 06, 2015 | Biopharmaceuticals |
Tunitas Therapeutics | Series A | September 30, 2015 | Biopharmaceuticals |
Surrozen | Series B | March 15, 2019 | Biopharmaceuticals |
RevOpsis Therapeutics | Seed | April 25, 2024 | Biopharmaceuticals |
Teewinot Life Sciences | Series B | May 02, 2017 | Biopharmaceuticals |
Surf Bio | Seed | April 12, 2022 | Biopharmaceuticals |
Rheos Medicines | Series A | March 22, 2018 | Biopharmaceuticals |
Sienna Biopharmaceuticals | Series A | April 29, 2016 | Biopharmaceuticals |
Tricida, Inc. | Series B | March 04, 2015 | Biopharmaceuticals |
Recida Therapeutics | Series A | February 06, 2019 | Biopharmaceuticals |
Trace Neuroscience | Series A | November 12, 2024 | Biopharmaceuticals |
Spero Therapeutics | Series A | June 08, 2015 | Biopharmaceuticals |
twoXAR | Series A | March 19, 2018 | Biopharmaceuticals |
TORL BioTherapeutics | Series B | April 13, 2023 | Biopharmaceuticals |
Travecta Therapeutics | Series A | May 12, 2020 | Biopharmaceuticals |
Stargazer Pharmaceuticals | Series A | November 09, 2020 | Biopharmaceuticals |
Tvardi Therapeutics | Series A | September 22, 2018 | Biopharmaceuticals |
Rubedo Life Sciences | Seed | December 03, 2020 | Biopharmaceuticals |
Tarsus Pharmaceuticals | Series B | January 08, 2020 | Biopharmaceuticals |
Terns Pharmaceuticals | Series C | January 06, 2021 | Biopharmaceuticals |
VelosBio | Series A | October 01, 2018 | Biopharmaceuticals |
VeraDermics | Series B | December 18, 2024 | Biopharmaceuticals |
Vasa Therapeutics | Seed | January 03, 2024 | Biopharmaceuticals |
Vedere Bio ll | Series A | May 18, 2021 | Biopharmaceuticals |
XTuit Pharmaceuticals | Series A | June 11, 2015 | Biopharmaceuticals |
Zentalis Pharmaceuticals | Series C | December 09, 2019 | Biopharmaceuticals |
Xeris Pharmaceuticals | Series A | May 19, 2017 | Biopharmaceuticals |
Y-mAbs Therapeutics | HBM Healthcare Investments | October 26, 2017 | Biopharmaceuticals |
Kexing Biopharm | IND Clearance | May 29, 2025 | Biopharmaceuticals |
SiteOne Therapeutics | Series C | December 18, 2024 | Biopharmaceuticals |
Angitia Biopharmaceuticals | Series C | May 30, 2025 | Biopharmaceuticals |
Maze Therapeutics | Series D | June 08, 2025 | Biopharmaceuticals |
Shape Biopharmaceuticals | Grant | June 09, 2025 | Biopharmaceuticals |
Trace Neuroscience | Series A | June 09, 2025 | Biopharmaceuticals |
Seaport Therapeutics | Series B | June 09, 2025 | Biopharmaceuticals |
Be Bio | Series A | October 24, 2024 | Biopharmaceuticals |